Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.

BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial. The LEADR trial ...

AtaCor, a cardiac rhythm management (CRM) company, develops extravascular defibrillation technologies. Its offerings aim to ...

A small-diameter, defibrillation lead that can be delivered through existing commercially available catheters for targeted placement is durable and safe, with no incidence of fractures at 1 year, the ...

Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...

Trinity Health Ann Arbor has completed Michigan’s first implant of the world’s smallest device designed to help treat ...

The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.

The US Food and Drug Administration has approved Medtronic's novel "extravascular" implantable cardioverter-defibrillator (Aurora EV-ICD) system, which uses a single lead implanted substernally to ...